FDA NDC Directory · JSON-LD · Markdown

Buprenorphine

NDC 3215-1525 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Labeler / ManufacturerAveva Drug Delivery Systems Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210272
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsBUPRENORPHINE (20 ug/h)
Marketing started20231101
Package count1

External sources

Source: openFDA. Public-domain (CC0).